Mitchell Sinkler & Starr’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Sell
602
-105
-15% -$50.4K 0.13% 129
2026
Q1
$348K Hold
707
0.16% 118
2025
Q4
$410K Hold
707
0.19% 109
2025
Q3
$343K Buy
707
+15
+2% +$6.98K 0.15% 121
2025
Q2
$281K Buy
692
+70
+11% +$29.3K 0.13% 128
2025
Q1
$310K Hold
622
0.09% 133
2024
Q4
$324K Buy
622
+35
+6% +$19.2K 0.09% 131
2024
Q3
$363K Buy
587
+50
+9% +$29.6K 0.09% 125
2024
Q2
$290K Sell
537
-26
-5% -$14.9K 0.07% 129
2024
Q1
$327K Sell
563
-169
-23% -$94.8K 0.08% 129
2023
Q4
$389K Buy
732
+103
+16% +$49.9K 0.07% 145
2023
Q3
$318K Sell
629
-14
-2% -$7.46K 0.1% 97
2023
Q2
$335K Hold
643
0.1% 117
2023
Q1
$371K Sell
643
-59
-8% -$33.3K 0.11% 106
2022
Q4
$387K Buy
702
+44
+7% +$23.3K 0.12% 106
2022
Q3
$334K Buy
658
+68
+12% +$38.1K 0.13% 90
2022
Q2
$321K Hold
590
0.12% 93
2022
Q1
$348K Hold
590
0.11% 97
2021
Q4
$394K Hold
590
0.12% 91
2021
Q3
$337K Buy
590
+153
+35% +$84K 0.3% 82
2021
Q2
$220K Buy
+437
New +$206K 0.2% 102

Other funds holding TMO

Mitchell Sinkler & Starr's TMO Position: Q2 2026 in Review

Mitchell Sinkler & Starr reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $50.4K and leaving 602 shares worth $302K. The position accounts for 0.13% of the portfolio, ranked #129.

Mitchell Sinkler & Starr first reported a position in TMO in Q2 2021 and has held it in 21 quarters since. The position peaked at $410K in Q4 2025. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Mitchell Sinkler & Starr held 602 shares of Thermo Fisher Scientific worth $302K as of Q2 2026.
  • Mitchell Sinkler & Starr sold 105 Thermo Fisher Scientific shares in Q2 2026, an estimated $50.4K.
  • Thermo Fisher Scientific made up 0.13% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #129 holding.
  • Mitchell Sinkler & Starr first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 21 quarters since.
  • Mitchell Sinkler & Starr's Thermo Fisher Scientific position peaked at $410K in Q4 2025.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.